Presage Biosciences is dedicated to improving the cancer drug development process so that patients can receive the most effective treatment possible.

Our proprietary technology platform allows for the rapid, reliable assessment of multiple cancer therapeutics in an in vivo setting, providing the first side-by-side comparison of multiple drugs and drug combinations within a single living tumor.

This patented technology heralds a new, innovative approach to select optimal drug candidates and efficiently advance cancer therapeutics to the market.

Presage was founded in 2008 based on technology invented in the lab of Dr. James Olson, a pediatric oncologist with the Fred Hutchinson Cancer Research Center, who was seeking a method to overcome the limitations inherent in the evaluation of cancer drugs.

Presage is a privately held company led by an experienced management team and is headquartered in Seattle.